BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22241505)

  • 1. Cancer complementary and alternative medicine research at the US National Cancer Institute.
    Jia L
    Chin J Integr Med; 2012 May; 18(5):325-32. PubMed ID: 22241505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The experiences of persons living with HIV who participate in mind-body and energy therapies: a systematic review protocol of qualitative evidence.
    Bremner M; Blake B; Stiles C
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):41-9. PubMed ID: 26571281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.
    Jia L; Lin H; Oppenheim J; Howard OMZ; Li J; Fan H; Zhao Z; Farrar W; Zhang Y; Colburn N; Young MR; Li W; Newman D; O'Keefe BR; Beutler J; Liu J; Hao X; Yang X; Ji T; White JD
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary and alternative medicine research: a National Cancer Institute perspective.
    White JD
    Semin Oncol; 2002 Dec; 29(6):546-51. PubMed ID: 12516037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of complementary and alternative medicine practitioners regarding cancer management and research.
    Colleen Lee CD; Zia F; Olaku O; Michie J; White JD
    J Soc Integr Oncol; 2009; 7(1):26-34. PubMed ID: 19476732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of complementary and alternative medicine for cancer.
    Kronenberg F; Mindes J; Jacobson JS
    Cancer Invest; 2005; 23(5):420-6. PubMed ID: 16193642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology.
    Ludmir EB; Jethanandani A; Mainwaring W; Miller AB; Lin TA; Espinoza AF; Verma V; VanderWalde NA; Grossberg AJ; Guadagnolo BA; Koong AC; Jagsi R; Thomas CR; Fuller CD
    J Natl Cancer Inst; 2019 Dec; 111(12):1358-1360. PubMed ID: 31165160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.
    Lee CO
    Clin J Oncol Nurs; 2004 Apr; 8(2):212-4. PubMed ID: 15108425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental therapeutics: review of biologically based CAM therapies for potential application in children with cancer: part I.
    Melnick SJ
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):221-30. PubMed ID: 16679919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmacologic and herbal therapies for cancer: research update from NCCAM.
    Richardson MA
    J Nutr; 2001 Nov; 131(11 Suppl):3037S-40S. PubMed ID: 11694644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.
    White JD
    J Altern Complement Med; 2002 Oct; 8(5):545-50. PubMed ID: 12470434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using factor analysis to create complementary and alternative medicine domains: an examination of patterns of use.
    Ayers SL; Kronenfeld JJ
    Health (London); 2010 May; 14(3):234-52. PubMed ID: 20427632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center.
    Judson PL; Abdallah R; Xiong Y; Ebbert J; Lancaster JM
    Integr Cancer Ther; 2017 Mar; 16(1):96-103. PubMed ID: 27444312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medical therapies for children with cancer.
    Kelly KM
    Eur J Cancer; 2004 Sep; 40(14):2041-6. PubMed ID: 15341976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary medicine in palliative care and cancer symptom management.
    Mansky PJ; Wallerstedt DB
    Cancer J; 2006; 12(5):425-31. PubMed ID: 17034678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of traditional Chinese medicine in United States].
    Tian XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):715-9. PubMed ID: 23073580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of cancer researchers regarding complementary and alternative medicine.
    Smith WB; Olaku O; Michie J; White JD
    J Soc Integr Oncol; 2008; 6(1):2-12. PubMed ID: 18302905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center.
    Abdallah R; Xiong Y; Lancaster JM; Judson PL
    Int J Gynecol Cancer; 2015 Nov; 25(9):1724-30. PubMed ID: 26397156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.